Medical Technology and Material Laboratory, Research and Business Development Division, Asahi Kasei Medical Co., LTD., 2-1, Samejima, Fuji-City, Shizuoka, 416-8501, Japan.
J Artif Organs. 2021 Sep;24(3):412-416. doi: 10.1007/s10047-020-01224-6. Epub 2020 Nov 16.
One of the often-used methods for in vitro evaluation of the blood compatibility of hemodialysis membranes is the circulation of human blood through a miniaturized hemodialyzer. The use of a rather small amount of human blood in its evaluation is one advantage of this method. However, because it is manufactured by a different process than actual ones, a miniaturized hemodialyzer membrane cannot always preserve the properties of actual hemodialyzers. To address this problem, we established a new experimental method that uses a relatively small amount of human blood and actual dialyzers. In this method, a test hemodialyzer and a control hemodialyzer filled with human blood obtained from the same donor is slowly rotated to prevent spontaneous blood cell sedimentation for 4 h at 37 °C. By use of this method, we were able to compare blood compatibility between a polysulfone (PS) membrane and a vitamin E (VE)-bonded PS membrane in terms of their relative antithrombotic, antioxidative, and anti-inflammatory properties. Consistent with many previous reports, the results clearly showed that compared with the PS membrane, VE-bonded PS membrane is more blood compatible. These findings suggest that our method is applicable, at least to in vitro blood compatibility evaluation of PS type dialysis membranes.
一种常用于评估血液透析膜血液相容性的体外方法是将人血循环通过小型化血液透析器。这种方法的一个优点是在评估中使用相当少量的人血。然而,由于它是通过与实际过程不同的工艺制造的,因此小型化血液透析器膜并不总能保留实际血液透析器的特性。为了解决这个问题,我们建立了一种新的实验方法,该方法使用相对少量的人血和实际的血液透析器。在这种方法中,测试血液透析器和充满从同一供体获得的人血的对照血液透析器在 37°C 下以缓慢旋转的方式防止自发血细胞沉降 4 小时。通过使用这种方法,我们能够比较聚砜(PS)膜和维生素 E(VE)键合 PS 膜之间的血液相容性,评估它们的相对抗血栓形成、抗氧化和抗炎特性。与许多先前的报告一致,结果清楚地表明,与 PS 膜相比,VE 键合 PS 膜具有更好的血液相容性。这些发现表明,我们的方法至少适用于 PS 型透析膜的体外血液相容性评估。